BIOTIME INC Purchase Agreements
7 Contracts & Agreements
- Form of Securities Purchase Agreement dated November 19, 2024, between Lineage Cell Therapeutics, Inc. and Broadwood Partners, L.P (Filed With SEC on November 20, 2024)
- Form of Securities Purchase Agreement dated November 19, 2024, between Lineage Cell Therapeutics, Inc. and the purchaser parties thereto (Filed With SEC on November 20, 2024)
- Option to Purchase Shares of AgeX Therapeutics, Inc., dated August 4, 2017, granted by BioTime, Inc. to Alfred D. Kingsley (Filed With SEC on November 9, 2017)
- Alternate Form of Securities Purchase Agreement (Filed With SEC on August 29, 2016)
- Form of Securities Purchase Agreement (Filed With SEC on August 29, 2016)
- Purchase Agreement, dated June 13, 2014, between The George Karfunkel 2007 Grantor Trust #1 and Asterias Biotherapeutics, Inc (Filed With SEC on August 11, 2014)
- Purchase Agreement, dated June 13, 2014, between Broadwood Partners, L.P. and Asterias Biotherapeutics, Inc (Filed With SEC on August 11, 2014)
